U.S. elections may thwart Democratic effort to cap insulin cost
By Ahmed Aboulenein WASHINGTON (Reuters) – U.S. lawmakers attempting to cut the cost of insulin for more than a million Americans to $35 per month are unlikely to succeed as November elections draw near and complicate bipartisan support, health policy and political experts say. The U.S. House of Representatives in March passed a bill capping …
U.S. elections may thwart Democratic effort to cap insulin cost Read More »










